Efficient bone formation by gene transfer of human LIM mineralization protein-3

Gene Therapy

Volumn 11, Issue 8, 2004, Pages 683-693

  Pola, E ^a,b,c   Gao, W ^b   Zhou, Y ^b   Pola, R ^c   Lattanzi, W ^b   Sfeir, C ^d   Gambotto, A ^a,b   Robbins, P D ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; BMP; Bone healing; Gene therapy; LMP

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; HOMEODOMAIN PROTEIN; ISOPROTEIN; LIM PROTEIN; OSTEOCALCIN; SIALOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTOR FACTOR OSX; TRANSCRIPTOR FACTOR RUNX; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUMBAR SPINE; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; SKELETAL MUSCLE; SPINE FUSION; THORACIC SPINE; VIRAL GENE DELIVERY SYSTEM;

3T3 CELLS; ADENOVIRIDAE; ALKALINE PHOSPHATASE; AMINO ACID SEQUENCE; ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; CELL LINE; CHORISTOMA; GENE THERAPY; GENETIC VECTORS; HOMEODOMAIN PROTEINS; HUMANS; INJECTIONS, INTRAMUSCULAR; MICE; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; OSTEOCALCIN; OSTEOPONTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRIDAE; ANIMALIA; MURINAE;

EID: 1942441646     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302207     Document Type: Article

References (31)

1. Boden SD et al. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. Endocrinology 1998; 139: 5125-5134.
2. Liu Y et al. Overexpressed LIM mineralization proteins do not require LIM domains to induce bone. J Bone Miner Res 2002; 17: 406-414.
3. Minamide A et al. Mechanism of bone formation with gene transfer of the cDNA encoding for the intracellular protein LMP-1. J Bone Joint Surg Am 2003; 85-A: 1030-1039.
4. Boden SD et al. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 1998; 23: 2486-2492.
5. Boden SD. Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation. Tissue Eng 2000; 6: 383-399.
6. Viggeswarapu M et al. Adenoviral delivery of LIM mineralization protem-1 induces new-bone formation in vitro and in vivo. J Bone Joint Surg Am 2001; 83-A: 364-376.
7. Kim HS et al. Overcoming the immune response to permit ex vivo gene therapy for spine fusion with human Type 5 adenoviral delivery of the LIM mineralization protein-1 cDNA. Spine 2003; 28: 219-226.
8. Schiller PC, D'Ippolito G, Roos BA, Howard GA. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J Bone Miner Res 1999; 14: 1504-1512.
9. Roth JA, Kim BG, Lin WL, Cho MI. Melatonin promotes osteoblasts differentiation and bone formation. J Biol Chem 1999; 274: 22041-22047.
10. Lai CF, Cheng SL. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-β in normal human osteoblastic cells. J Biol Chem 2002; 277: 15514-15522.
11. Spinella-Jaegle S et al. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differentiation. Bone 2001; 29: 323-330.
12. Shui C, Scutt AM. Mouse embryo-derived NIH3T3 fibroblasts adopt an osteoblast-like phenotype when treated with 1alpha,25-dihydroxyvitamin D(3) and dexamethasone in vitro. J Cell Physiol 2002; 193: 164-172.
13. Xiao ZS, Hinson TK, Quarles LD. Cbfa isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells. J Cell Biochem 1999; 74: 596-605.
14. Rutherford RB et al. Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng 2002; 8: 441-452.
15. Wang EA, Israel DI, Kelly S, Luxenberg DP. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factor 1993; 9: 57-71.
16. Cheng SL et al. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calcif Tissue Int 2001; 68: 87-94.
17. b-tsA58 transgenic mouse. J cell Physiol 1996; 167: 523-538.
18. Dragoo JL et al. Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res 2003; 21: 622-629.
19. Musgrave DS et al. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 1999; 24: 541-547.
20. Bunyaratavej P, Hollinger T, Somerman M. Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells. Exp Cell Res 2000; 260: 324-333.
21. Baltzer AW et al. A gene therapy approach to accelerating bone healing. Evaluation of gene expression in a New Zealand white rabbit model. Knee Surg Sports Traumatol Arthrosc 1999; 7: 197-202.
22. Bouxsein ML et al. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg Am 2001; 83-A: 1219-1230.
23. Niyibizi C et al. Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop 1998(355 Suppl): S148-S153.
24. Baltzer AW et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Therapy 2000; 7: 734-739.
25. Niyibizi C, Kim M. Novel approaches to fracture healing. Expert Opin Investig Drugs 2000; 9: 1573-1580.
26. Baltzer AW et al. Potential role of direct adenoviral gene transfer in enhancing fracture repair. Clin Orthop 2000(379 Suppl): S120-S125.
27. Goldstein SA. In vivo nonviral delivery factors to enhance bone repair. Clin Orthop 2000(379 Suppl): S113-S119.
28. Nakashima K et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108: 17-29.
29. Gao W et al. A web-based DNA codon optimization algorithm. Biotechnol Prog, In Press.
30. Quarles LD et al. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 1992; 7: 683-692.
31. Franceschi RT, Iyer BS, Chi Y. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 1994; 9: 843-854.